Neurify Biosciences

Neurify Biosciences is a consulting firm empowering biotech companies with expert guidance in neurodegeneration and advanced disease modeling. We specialize in human-relevant systems—organ chips, iPSC-derived models, and other New Approach Methodologies (NAMs)—to bridge the gap between preclinical research and translational strategy. With recent FDA and NIH momentum behind NAMs, including regulatory acceptance of organ-on-chip data and expanded NIH support, we help clients de-risk programs, design predictive assays, and align with the next generation of non-animal, human-based drug development tools. Driving innovation from bench to bedside—smarter, faster, and more human-relevant.